| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 3201.62 | 99 |
| GSM780708 | Untreated after 4 days (C2_1) | 3484.99 | 99 |
| GSM780709 | Untreated after 4 days (C3_1) | 2837.18 | 98 |
| GSM780719 | Untreated after 4 days (C1_2) | 3114.79 | 99 |
| GSM780720 | Untreated after 4 days (C2_2) | 3767.41 | 99 |
| GSM780721 | Untreated after 4 days (C3_2) | 2754.49 | 98 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 2979.88 | 99 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 3366.97 | 99 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 2661.29 | 98 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 2817.78 | 98 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 3325.46 | 99 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 2848.2 | 98 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 2432.25 | 98 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 2262.68 | 98 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 2549.45 | 98 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 2654.45 | 98 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 2417.41 | 98 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 2798.19 | 98 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 3885.25 | 99 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 3283.62 | 99 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 3480.87 | 99 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 3723.57 | 99 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 3596.65 | 99 |